Purple Biotech Ltd

Research Purple Biotech Ltd (PPBT) on Bullrun: market cap USD 1.62M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPPBT
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.62M
• Financial periodFY2021
• Net incomeUSD 17.83M

Valuation Snapshot

latest market cap is USD 1.62M.

About Purple Biotech Ltd

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma;

Frequently asked questions

What is Purple Biotech Ltd's market cap?

Purple Biotech Ltd's market capitalization is USD 1.62M.

What does Purple Biotech Ltd do?

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.